Terms: = Uterine cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
551 results:
1. A Comparative Study of Clinical Outcomes in Locally Advanced Cervical cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
[TBL] [Abstract] [Full Text] [Related]
2. A Comparative Study of Deep Learning Dose Prediction Models for Cervical cancer Volumetric Modulated Arc Therapy.
Wu Z; Liu M; Pang Y; Deng L; Yang Y; Wu Y
Technol Cancer Res Treat; 2024; 23():15330338241242654. PubMed ID: 38584413
[No Abstract] [Full Text] [Related]
3. Health related quality of life and its predictive factors on cervical cancer patients in two teaching hospitals, Addis Ababa, Ethiopia.
Seyfu DT; Abebe SN; Haile S; Ayana BA
BMC Womens Health; 2024 Apr; 24(1):209. PubMed ID: 38566073
[TBL] [Abstract] [Full Text] [Related]
4. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
[TBL] [Abstract] [Full Text] [Related]
5. Comparative effectiveness of implementation strategies for Accelerating Cervical cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria.
Olakunde BO; Itanyi IU; Olawepo JO; Liu L; Bembir C; Idemili-Aronu N; Lasebikan NN; Onyeka TC; Dim CC; Chigbu CO; Ezeanolue EE; Aarons GA
Implement Sci; 2024 Mar; 19(1):25. PubMed ID: 38468266
[TBL] [Abstract] [Full Text] [Related]
6. Elevated INHBA Promotes Tumor Progression of Cervical cancer.
Wu Z; Chen J; Yang L; Sun K; Jiang Q; Dong F; Lu W; Chen R; Chen Y
Technol Cancer Res Treat; 2024; 23():15330338241234798. PubMed ID: 38419562
[No Abstract] [Full Text] [Related]
7. Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
Wang J; Mou X; Lu H; Jiang H; Xian Y; Wei X; Huang Z; Tang S; Cen H; Dong M; Liang Y; Shi G
Front Endocrinol (Lausanne); 2023; 14():1302074. PubMed ID: 38327905
[TBL] [Abstract] [Full Text] [Related]
8. Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy.
Gori S; Frayle H; Pagan A; Soldà M; Romagnolo C; Insacco E; Laurino L; Matteucci M; Sordi G; Busato E; Zorzi M; Maggino T; Del Mistro A;
Fam Med Community Health; 2024 Feb; 12(Suppl 2):. PubMed ID: 38307701
[TBL] [Abstract] [Full Text] [Related]
9. Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
Bridge F; Brotherton J; Stankovich J; Sanfilippo PG; Skibina OG; Buzzard K; Kalincik T; Nguyen AL; Guo K; Monif M; Wrede CD; Rath L; Taylor L; Butzkueven H; Jokubaitis VG; Van Der Walt A
Neurology; 2024 Feb; 102(4):e208059. PubMed ID: 38306594
[TBL] [Abstract] [Full Text] [Related]
10.
Zhang YT; Xu LJ; Li L
Genet Test Mol Biomarkers; 2024 Jan; 28(1):10-21. PubMed ID: 38294357
[No Abstract] [Full Text] [Related]
11. Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial cancer.
Zheng S; Donnelly ED; Strauss JB
JAMA Netw Open; 2024 Jan; 7(1):e2351906. PubMed ID: 38231514
[TBL] [Abstract] [Full Text] [Related]
12. Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study.
Cilla S; Campitelli M; Antonietta Gambacorta M; Michela Rinaldi R; Deodato F; Pezzulla D; Romano C; Fodor A; Laliscia C; Trippa F; De Sanctis V; Ippolito E; Ferioli M; Titone F; Russo D; Balcet V; Vicenzi L; Di Cataldo V; Raguso A; Giuseppe Morganti A; Ferrandina G; Macchia G
Radiother Oncol; 2024 Feb; 191():110072. PubMed ID: 38142932
[TBL] [Abstract] [Full Text] [Related]
13. [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
Cui HX; Lou XL; Xia W; Zhang YS; Cheng XY; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3967-3971. PubMed ID: 38129175
[TBL] [Abstract] [Full Text] [Related]
14. Digital health interventions for cervical cancer care: A systematic review and future research opportunities.
Razzak MA; Islam MN; Aadeeb MS; Tasnim T
PLoS One; 2023; 18(12):e0296015. PubMed ID: 38100494
[TBL] [Abstract] [Full Text] [Related]
15. Radiomics model based on multi-sequence MRI for preoperative prediction of ki-67 expression levels in early endometrial cancer.
Ding SX; Sun YF; Meng H; Wang JN; Xue LY; Gao BL; Yin XP
Sci Rep; 2023 Dec; 13(1):22052. PubMed ID: 38086918
[TBL] [Abstract] [Full Text] [Related]
16. IRX2 regulates endometrial carcinoma oncogenesis by transcriptional repressing RUVBL1.
Xu Q; Zhou W; Zhou Y; Zhang X; Jiang R; Ai Z; Chen J; Ma L
Exp Cell Res; 2024 Jan; 434(1):113866. PubMed ID: 38042247
[TBL] [Abstract] [Full Text] [Related]
17. Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data.
Xu T; Jiang J; Xiang X; Jahanshahi H; Zhang Y; Chen X; Li L
Comput Biol Med; 2024 Jan; 168():107656. PubMed ID: 38029530
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA-sequencing and methylation modification data in endometrial cancer.
Zhou H; Zhang Y; Jin J; Shen K; Yang Y; Lao P
J Gene Med; 2024 Jan; 26(1):e3638. PubMed ID: 38011892
[TBL] [Abstract] [Full Text] [Related]
19. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
20. 3D-US and CBCT Dual-guided Radiotherapy for Postoperative uterine Malignancy: A Primary Workflow set-up.
Li Y; Gong Z; Liu M; Li H; Gao H; Guo C; Yu L; Zhu C; Sun Z; Sun L; Xu H; He X
Technol Cancer Res Treat; 2023; 22():15330338231212082. PubMed ID: 37993995
[No Abstract] [Full Text] [Related]
[Next]
